Valuation: Eckert & Ziegler SE

Market Cap 758M 870M 716M 650M 1.22B 83.46B 1.22B 8.58B 3.31B 42.43B 3.27B 3.19B 137B P/E 2026 *
14.8x
P/E 2027 * 14x
Enterprise Value 643M 737M 607M 551M 1.03B 70.72B 1.04B 7.27B 2.81B 35.95B 2.77B 2.71B 116B EV / Sales 2026 *
2.02x
EV / Sales 2027 * 1.86x
Free-Float
67.36%
Yield 2026 *
1.73%
Yield 2027 * 1.77%
1 week-0.82%
Current month-6.46%
1 month-9.05%
3 months-21.75%
6 months-15.44%
Current year-20.16%
1 week 12.01
Extreme 12.01
12.56
1 month 12.01
Extreme 12.01
13.75
3 years 9.63
Extreme 9.6333237
23.03
5 years 9.63
Extreme 9.62665704
46.8
10 years 1.69
Extreme 1.6874983125
47.13
Manager TitleAgeSince
Chief Executive Officer 59 2023-06-06
Chief Tech/Sci/R&D Officer - 2024-12-31
Chief Operating Officer 59 2024-12-31
Director TitleAgeSince
Chairman 57 2023-06-06
Director/Board Member 66 2013-12-31
Director/Board Member 58 2016-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.58%-0.82%-32.59%+20.96% 870M
-0.38%+8.47%+17.88%-22.53% 17.65B
+0.57%+7.59%-40.66%+36.28% 1.89B
-0.37%-2.27%-33.57%+24.26% 870M
-0.27%+0.16%+50.57%+1.04% 779M
-4.24%-9.85%-63.10%-85.54% 728M
+1.13%+0.56%-35.58%-50.30% 642M
-0.97%-1.08%-43.59%-54.34% 555M
-2.13%-2.87%-45.48%-39.20% 439M
-4.10%+10.61%+44.25%+74.34% 435M
Average -1.18%+0.93%-18.19%-9.50% 2.67B
Weighted average by Cap. -0.49%+4.83%+5.12%-16.04%

Financials

2026 *2027 *
Net sales 318M 365M 300M 273M 511M 34.99B 513M 3.6B 1.39B 17.79B 1.37B 1.34B 57.24B 342M 392M 323M 293M 549M 37.61B 551M 3.87B 1.49B 19.12B 1.47B 1.44B 61.53B
Net income 51.68M 59.27M 48.8M 44.31M 83.02M 5.69B 83.37M 585M 226M 2.89B 223M 218M 9.3B 53.08M 60.88M 50.12M 45.52M 85.28M 5.84B 85.64M 600M 232M 2.97B 229M 224M 9.56B
Net Debt -116M -133M -109M -99.26M -186M -12.74B -187M -1.31B -505M -6.48B -499M -488M -20.84B -123M -140M -116M -105M -197M -13.48B -198M -1.39B -535M -6.85B -528M -516M -22.05B
Logo Eckert & Ziegler SE
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Employees
-
Date Price Change
26-09-21 12.09 -0.58%
26-09-18 €12.16 -0.41%
26-09-17 €12.21 +0.99%
26-09-16 €12.09 -2.03%
26-09-15 €12.34 -0.48%
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
12.12EUR
Average target price
21.60EUR
Spread / Average Target
+78.22%

Annual profits - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!